Evidence map›Paper›PMID 42588668›Full record

ArticleCancers2026

Sub-Saharan African Prostate Cancer Patient-Derived Cell Lines and High-Throughput Drug Screening: Addressing Ancestry Underrepresentation in Oncobiology Research.

Carla S Dos Santos, Ana C Magalhães, Veronica Fernandes, António Pombinho, Lurdes Torres, Margarida André, Adelaide Sousa, Pedro Sequeira, Daniel Pinto, Cláudia Pereira and 3 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Carla S Dos Santosi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-0960-4818
Ana C Magalhãesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-3988-3280
Veronica Fernandesi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-3873-2034
António Pombinhoi3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-6427-1374
Lurdes TorresInstituto Português de Oncologia do Porto, 4200-072 Porto, Portugal.
Margarida AndréUnidade Local de Saúde Almada-Seixal, 2805-267 Almada, Portugal.ORCID 0000-0002-5918-8621
Adelaide SousaUnidade Local de Saúde Almada-Seixal, 2805-267 Almada, Portugal.
Pedro SequeiraUnidade Local de Saúde Almada-Seixal, 2805-267 Almada, Portugal.
Daniel PintoUnidade Local de Saúde Almada-Seixal, 2805-267 Almada, Portugal.
Cláudia PereiraUnidade Local de Saúde Almada-Seixal, 2805-267 Almada, Portugal.
Paulo M CostaUnidade Local de Saúde Almada-Seixal, 2805-267 Almada, Portugal.ORCID 0000-0002-7550-8285
Lúcio Lara SantosInstituto Português de Oncologia do Porto, 4200-072 Porto, Portugal.
Luisa Pereirai3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, 4200-135 Porto, Portugal.ORCID 0000-0002-4271-1527

Funding

FCT POCI-01-0145-FEDER-007274FCT PTDC/BIAMOL/3986/2021FCT UI/BD/153041/2022Liga Portuguesa Contra o Cancro - Núcleo Regional do Norte Bolsas LPCC-NRN 2026
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

high-throughput drug screeningpatient-derived cell linesprostate cancersub-Saharan African ancestry

Identifiers

PMID42588668
PMCPMC13465145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.